Clinical Trials Directory

Trials / Completed

CompletedNCT05166798

Optimal Dose of a Cognitive Control Training for Depression Vulnerability

Establishing a Dose-response Relationship for the Effects of a Cognitive Control Training on Depression Vulnerability

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
216 (actual)
Sponsor
University Ghent · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

This study aims to examine the dose-response relationship of an online adaptive cognitive control training on depressive symptomatology and rumination. Participants will be randomized over six groups, each receiving a different dose (0, 1, 5, 10, 15 or 20 sessions) of a cognitive control training in remitted depressed patients. An adaptive Paced Auditory Serial Addition Task will be used as cognitive control training.

Detailed description

Depression is often associated with cognitive impairments and recent studies have found that for some people, these cognitive problems persist after remission of depression. These cognitive impairments could be a risk factor for recurrence of depressive episodes. Cognitive control training aims to address these cognitive impairments and decrease the risk of recurrence of depression. One promising operationalization of cognitive control training is the adaptive Paced Auditory Serial Addition Task, but currently, it's unclear how many sessions one should complete in order to obtain cognitive- and emotional transfer effects. By comparing multiple groups with a different number of sessions (0, 1, 5, 10, 15 and 20), with measures at post (one month after baseline) and two follow-up periods (at 3 months and 6 months after baseline), this study examines the effects of an online cognitive control training on depressive vulnerability factors.

Conditions

Interventions

TypeNameDescription
BEHAVIORALCognitive control trainingThe five intervention groups will receive either 1, 5, 10, 15 or 20 training sessions with the Adaptive Paced Auditory Serial Addition Task (aPASAT).

Timeline

Start date
2022-02-01
Primary completion
2023-11-22
Completion
2023-11-22
First posted
2021-12-22
Last updated
2024-01-03

Locations

2 sites across 1 country: Belgium

Source: ClinicalTrials.gov record NCT05166798. Inclusion in this directory is not an endorsement.